Form 4: AtriCure Chief Scientific Officer Boosts Stake Through Employee Stock Purchase Plan

AtriCure's Chief Scientific Officer, Vinayak Doraiswamy, acquired 822 shares of common stock at a discounted price of $25.84 per share through the company's Employee Stock Purchase Plan.

Summary

• Vinayak Doraiswamy, Chief Scientific Officer of AtriCure, Inc. (ATRC), acquired 822 shares of the company's common stock.
• The transaction occurred on June 30, 2025, and was reported on July 2, 2025.
• The shares were purchased at a price of $25.84 per share.
• This acquisition was made pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan (ESPP).
• The purchase price of $25.84 represents 85% of the closing price of the issuer's common stock on January 2, 2025, which was $30.40.
• Following this transaction, Mr. Doraiswamy beneficially owns a total of 74,372 shares of AtriCure common stock.
• The transaction was executed under a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key officer, especially through a pre-planned employee stock purchase program, generally indicates management confidence in the company's future performance and aligns their interests with shareholders, contributing to a positive sentiment.

Positives

• The acquisition of shares by a Chief Scientific Officer indicates continued confidence in the company's future prospects and strategic direction.
• Participation in the Employee Stock Purchase Plan demonstrates alignment of management's interests with those of shareholders.
• The purchase was made at a discounted price, reflecting a benefit provided to employees through the ESPP.

Future Outlook

This transaction was executed as part of a pre-arranged Rule 10b5-1 trading plan, indicating a systematic and pre-determined approach to equity acquisition by the officer rather than a discretionary, market-timing decision.

Industry Context

Insider transactions, particularly acquisitions through employee benefit plans, are common across industries and often viewed as a positive signal of management's belief in the company's long-term value. This specific transaction aligns with typical corporate practices for employee stock purchase programs.

Comparison to Industry Standards

• The acquisition through an Employee Stock Purchase Plan (ESPP) at a discounted price is a standard benefit offered by many publicly traded companies to their employees, including executives, to encourage ownership and align interests.
• The size of the acquisition (822 shares) is typical for routine ESPP participation by an executive, rather than a large, strategic open-market purchase.

Related Party Transactions

• The acquisition of shares by the Chief Scientific Officer through the company's Employee Stock Purchase Plan constitutes a transaction between a related party (officer) and the company, which is a standard employee benefit program.

Stakeholder Impact

• Shareholders: The transaction signals management's confidence in the company, which can be viewed positively.
• Employees: Reinforces the value of employee stock purchase plans as a benefit.

Key Dates

Recommendation

Keywords

AtriCure, ATRC, Form 4, Insider Transaction, Employee Stock Purchase Plan, ESPP, Beneficial Ownership, Vinayak Doraiswamy, Common Stock, Officer Acquisition